Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

NCT00089167 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: filgrastim
DRUG: dexamethasone
DRUG: melphalan
DRUG: thalidomide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]